Inflammation in health and disease: a balancing act (information about the 16th World Congress on Inflammation (WCI2024)).

The following provides a summary of the 16th World Congress on Inflammation (WCI 2024), which took place in Québec City (Canada) from July 21 to 24, 2024. At the meeting, researchers from around the world presented their latest findings which transcended fundamental and clinical science in the field of inflammation. Participants shared original work which covered a multitude of topics and discussed practical aspects of their research including the application of new diagnostic strategies and medical therapeutic technologies.

Emerging Trends in Pathophysiology: Insights from the 9th International Congress of the International Society for Pathophysiology (ISP 2023).

This article provides a summary of the 9th International Congress of the International Society for Pathophysiology (ISP 2023) which took place in Belgrade, Serbia, from 4 to 6 July 2023. It describes the main trends and the most promising areas of research in current pathophysiology, including investigations of new pathogenic pathways, and the identification of cellular and molecular mechanisms, target molecules, genetic mechanisms, and new therapeutic strategies. The present article also highlights the research conducted by leading scientific teams and national pathophysiological societies from various countries that adds to our understanding of the pathogenesis of diseases and pathological processes.

Targeting the ATF6-Mediated ER Stress Response and Autophagy Blocks Integrin-Driven Prostate Cancer Progression.

Unlabelled: Prostate cancer progression to the lethal metastatic castration-resistant phenotype (mCRPC) is driven by αv integrins and is associated with Golgi disorganization and activation of the ATF6 branch of unfolded protein response (UPR). Overexpression of integrins requires N-acetylglucosaminyltransferase-V (MGAT5)-mediated glycosylation and subsequent cluster formation with Galectin-3 (Gal-3). However, the mechanism underlying this altered glycosylation is missing.

New frontiers in inflammation: from translational research to clinic (information about the 15th World Congress on Inflammation (WCI2022)).

The following provides a summary of the 15th World Congress on Inflammation (WCI2022), which took place in Rome (Italy) from June 5 to 8, 2022. Presented are the main trends and most promising research developments in the field of inflammation, including identification of cellular and molecular mechanisms and investigation of new pathogenetic pathways, target molecules, genetic mechanisms, and new therapeutic strategies. In addition, described are the primary areas of research engaged in by leading scientific groups and national societies from various countries in the field of inflammatory pathology mechanisms.

Post-genomic platform for development of oligonucleotide vaccines against RNA viruses: diamond cuts diamond.

The coronavirus pandemic has starkly demonstrated the need to create highly effective vaccines against various viral diseases. The emerging new platforms for vaccine creation (adenovirus vectors and mRNA vaccines) have shown their worth in the fight against the prevention of coronavirus infection. However, adenovirus vectors and mRNA vaccines have a serious disadvantage: as a rule, only the S protein of the coronavirus is presented as an antigen.